The most common adverse effects include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort
58-59 * signals cells to take in glucose as fuel--which they then do unless they've become insulin resistant
The mean incremental improvements in QALE with oral semaglutide 14 mg were 0.09, 0.18 and 0.07 QALYs versus empagliflozin 25 mg, sitagliptin 100 mg and liraglutide 1.8 mg, respectively
Rhonda Patrick: Back to my worm studies I was doing, I would elevate heat shock proteins in these worms, and it would totally correct the problem, where they would no longer become paralyzed
The approval was expanded in October 2025 to include cardiovascular risk reduction in people with Type 2 diabetes